Fungal infections in pediatric patients: challenges and considerations in treatment
There is and will be further needed therapeutic drug monitoring for all antifungal drugs in children. Prioritizing pediatric-specific research and developing standardized treatment protocols are crucial. Furthermore, regulatory reforms are essential to expedite access to new diagnostic and treatment strategies for IFD in children.
Authors
- Elio Castagnola (ORCID: https://orcid.org/0000-0002-5336-8429)
- Carolina Saffioti (ORCID: https://orcid.org/0000-0001-5336-0235)
- Erica Ricci (ORCID: https://orcid.org/0000-0003-4992-598X)
- Marcello Mariani (ORCID: https://orcid.org/0000-0003-2989-7301)
- Alessio Mesini (ORCID: https://orcid.org/0000-0003-0593-4112)
- Chiara Russo (ORCID: https://orcid.org/0000-0002-0917-1936)
Institutions
- Istituto Giannina Gaslini (IT)
Publication Details
- Journal
- Expert Review of Anti-infective Therapy
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1080/14787210.2025.2574707
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00